Development of new chromanol antagonists of leukotriene D4

Abstract By addressing the issues of potency and metabolism in 3 , a new series of LTD 4 antagonists represented by (+)- 26 was developed which is equipotent to clinical LTD 4 antagonists Zafirlukast ( 1 ) and Pranlukast ( 2 ).